Tempest Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Brisbane, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Tempest Therapeutics, Inc. has filed 1,021 SEC EDGAR filings since 09 Apr 2012

SEC filing history

Showing 301-325 of 1,000 matching filings.

Per page
25
Current page
13
425 File 001-35890

8-K

Filing date
11 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-255198

EFFECT filing

Filing date
11 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-255198

424B3

Filing date
11 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-4/A File 333-255198

S-4/A

Filing date
10 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-255261

S-8

Filing date
15 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-4 File 333-255198

S-4

Filing date
13 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87213

NEW ENTERPRISE ASSOCIATES 15, L.P. / MILLENDO THERAPEUTICS, INC. -- SCHEDULE 13D

Filing date
13 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SC 13G

Filing date
07 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

FORM 8-K

Filing date
29 Mar 2021
Reporting date
29 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-35890

FORM 8-K

Filing date
29 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SC 13G

Filing date
16 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

SC 13G/A filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
28 Jan 2021
Reporting date
22 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

FORM 8-K

Filing date
05 Jan 2021
Reporting date
05 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .